Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group

The Journal of Clinical Psychiatry
S ZisookI Grant

Abstract

The purpose of this randomized double-blind, placebo-controlled study was to compare the efficacy and safety of fluoxetine plus group psychotherapy versus group psychotherapy alone in HIV-seropositive men (based on 1986 CDC classes II, III, and IV.C.2) who had been diagnosed with major depressive disorder (DSM-III-R). During a 7-week trial, patients were treated with fluoxetine 20-60 mg or placebo 1-3 capsules per day and were seen in weekly supportive group psychotherapy. In addition, subjects were rated on the 17-item Hamilton Rating Scale for Depression (HAM-D-17), Clinical Global Impressions scales for Improvement (CGI-I) and Severity of Illness (CGI-S), and the short version of the Beck Depression Inventory (BDI-13). Of the 47 patients enrolled in the study, 25 were administered fluoxetine and 22 were given placebo. Subjects who received fluoxetine began to show significantly more improvement than patients who received placebo on both self- and observer-rated scales by the end of the first week of treatment. By endpoint, patients treated with fluoxetine experienced greater mean changes from baseline compared with placebo-treated patients on the HAM-D-17 (12.1 vs. 6.6; F = 6.53, df = 1,45; p < .05) and BDI-13 (5.9 vs. 1.2; ...Continue Reading

Citations

Jan 11, 2007·Wiener medizinische Wochenschrift·Hans-Bernd Rothenhäusler
Nov 9, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Seema SahaySanjay Mehendale
Oct 8, 2008·Current HIV/AIDS Reports·Judith G Rabkin
Apr 11, 2009·Current HIV/AIDS Reports·Kelly Brogan, Joseph Lux
Dec 21, 2000·Current Psychiatry Reports·L S Goldman
Oct 4, 2002·Biological Psychiatry·K Ranga R KrishnanCynthia Wainscott
Dec 26, 2001·Journal of Clinical Epidemiology·C H HinkinK Goodkin
Aug 4, 2011·Psychology, Health & Medicine·Lorraine SherrJose Catalan
Jan 12, 2013·AIDS Patient Care and STDs·Alan T Rodriguez-PenneyUNKNOWN HIV Neurobehavioral Research Program HNRP Group
Nov 6, 2001·The Western Journal of Medicine·R H Remien, J G Rabkin
May 1, 2001·Suicide & Life-threatening Behavior·D Hughes, P Kleespies
Feb 25, 2006·Primary Care Companion to the Journal of Clinical Psychiatry
Sep 12, 2006·Primary Care Companion to the Journal of Clinical Psychiatry·Tiziano ColibazziWilliam S Gilmer
Jan 25, 2014·Indian Journal of Psychiatry·Abhijit Ramanna HonagoduPeter Lepping
Jul 16, 2004·International Journal of Group Psychotherapy·Allen C ShermanBernhard Strauss
Feb 2, 2008·International Review of Psychiatry·Stephen J Ferrando, Zachary Freyberg
Oct 9, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Winfried RiefJerry Avorn
Aug 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Andrew A Pieper, Glenn J Treisman
May 16, 2007·Infectious Disease Clinics of North America·Carla J BergSteven A Safren
Jun 21, 2005·Journal of Advanced Nursing·Lucille Sanzero EllerPatrice Nicholas
May 2, 2003·Journal of Clinical Pharmacology·David J GreenblattRichard I Shader
Aug 9, 2005·Biological Psychiatry·Dwight L EvansWilliam J Valvo
Mar 27, 2002·The Psychiatric Clinics of North America·Michael J Robinson, Roula B Qaqish
Aug 2, 2003·Biological Psychiatry·Dean G CruessJohn M Petitto
Nov 19, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Joseph P SteinerAvindra Nath
Feb 1, 2003·Acta Psychiatrica Scandinavica·A Roy
Nov 25, 2004·The Annals of Pharmacotherapy·Joshua Caballero, Milap C Nahata
Jun 4, 2008·Psychosomatic Medicine·Martin J Repetto, John M Petitto
Jan 23, 2018·The Cochrane Database of Systematic Reviews·Ingrid Eshun-WilsonJohn A Joska
Feb 11, 2004·The Journal of Nervous and Mental Disease·Mark ZimmermanMichael A Posternak
Mar 16, 2017·The Cochrane Database of Systematic Reviews·Ingrid van der HeijdenDavid Sinclair
Dec 25, 2007·AIDS Patient Care and STDs·Jori A Berger-GreensteinTerence M Keane
Jan 13, 2009·AIDS Patient Care and STDs·Kathryn A Bottonari, Lara M Stepleman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.